Clinical Trials Browser

Has results × Prostatic Neoplasms × pazopanib × Clear all

NCT00454571 2016-02-10

Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer

Phase 2 Completed

37 enrolled 5 charts

Prostatic Neoplasms

NCT00945477 2013-11-18

Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade

Phase 2 Terminated

11 enrolled 6 charts

Prostatic Neoplasms